A committee in Switzerland’s National Council is planning to amend the banking law to raise capital requirements for systemically important banks. The proposal would take a different approach from the path previously recommended by the Federal Council. UBS shares retreated after the news emerged.

The European Union has approved a breast cancer drug combination jointly developed by AstraZeneca and Daiichi Sankyo. The decision grants the therapy market access across Europe.

CrowdStrike reported second-quarter results with revenue up 26% year over year to $1.47 billion. Annual recurring revenue (ARR) surged 51% from a year earlier. The company also raised its full-year guidance, underscoring continued strong demand for cybersecurity.

South Korea released its latest trade figures, showing total exports rose 68.7% year on year. Semiconductor exports were especially strong, surging 209% from a year earlier to a record high. The data lifted shares of Samsung Electronics and SK hynix.